NCT03158103 2021-04-30A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)Memorial Sloan Kettering Cancer CenterPhase 1 Completed3 enrolled